Advisor Resource Council’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,096
Closed -$245K 233
2025
Q1
$245K Buy
+4,096
New +$239K 0.02% 509
2024
Q1
Sell
-12,195
Closed -$626K 266
2023
Q4
$626K Buy
+12,195
New +$640K 0.07% 243
2022
Q3
Sell
-16,457
Closed -$1.27M 193
2022
Q2
$1.27M Buy
+16,457
New +$1.25M 0.12% 172
2022
Q1
Sell
-5,389
Closed -$336K 253
2021
Q4
$336K Buy
+5,389
New +$316K 0.03% 407
2021
Q3
Sell
-3,985
Closed -$266K 250
2021
Q2
$266K Buy
+3,985
New +$260K 0.03% 412

Other funds holding BMY

Advisor Resource Council's BMY Position: Q2 2025 in Review

Advisor Resource Council sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 4,096 shares — an estimated $245K sold.

Advisor Resource Council first reported a position in BMY in Q2 2021 and held it in 5 quarters. The position peaked at $1.27M in Q2 2022. 2,297 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

  • Advisor Resource Council reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
  • Advisor Resource Council sold 4,096 Bristol-Myers Squibb shares in Q2 2025, an estimated $245K.
  • Advisor Resource Council first reported a position in Bristol-Myers Squibb in Q2 2021 and held it in 5 quarters.
  • Advisor Resource Council's Bristol-Myers Squibb position peaked at $1.27M in Q2 2022.
  • 2,297 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on Advisor Resource Council's 13F filing for Q2 2025, filed 11 Aug 2025.